Common gout medicine may help in ACS

A COMMON gout medication could be an effective secondary prevention for patients with acute coronary syndrome, Australian research shows.

Colchicine (Lengout and Colgout, Aspen Pharmacare), an anti-inflammatory used to treat gouty arthritis, was shown to dramatically reduce heart inflammation and could have important therapeutic implications for cardiac patients, study authors suggest.

“Excitingly, we’ve been able to prove that this low-cost and widely available drug is both safe and profoundly effective in reducing local cardiac inflammation,” Dr Sanjay Patel, study author and